Principles of Pediatric Chemotherapy

Principles of Pediatric Chemotherapy

Principles of Pediatric Chemotherapy

On this page

Principles of Pediatric Chemotherapy - Tiny Patients, Big Differences

  • Pediatric physiology alters drug ADME (Absorption, Distribution, Metabolism, Excretion).
  • Dosing: Primarily Body Surface Area (BSA) based ($mg/m^2$).
    • Carboplatin: Calvert formula (Dose = Target AUC x (GFR + 25)).
  • Generally higher chemo tolerance & tumor sensitivity vs. adults.
  • Key focus: Minimizing long-term effects (growth, neurocognitive, fertility, secondary cancers).
  • Aggressive supportive care vital (hydration, antiemetics, G-CSF).
  • Multidisciplinary team (MDT) approach is crucial.

⭐ Pediatric cancers often show higher cure rates (e.g., ALL >80-90%) and better tolerance to intensive chemotherapy than adult cancers, but have a unique malignancy spectrum and long-term sequelae.

Principles of Pediatric Chemotherapy - Little Heroes' Weapons

  • Pediatric cancers often highly chemosensitive. Goal: Cure with minimal long-term effects.
  • Targets rapidly dividing cells. Combination regimens are standard.
  • Key principles: cell cycle specificity, dose intensity, minimizing toxicity.
  • 📌 Cell Cycle: M-phase (Vinca), S-phase (Antimetabolites, Etoposide), G2 (Bleomycin). Non-specific: Alkylating, Anthracyclines.

Chemotherapy drug classes and cell cycle targets

Drug ClassMoAExamplesUsesToxicities
Alkylating AgentsCross-link DNACyclophosphamideLeukemias, lymphomas, solid tumorsMyelosuppression, hemorrhagic cystitis, 2° Malign
AntimetabolitesBlock DNA/RNA synthesisMethotrexate, 6-MPLeukemias (ALL), lymphomasMyelosuppression, mucositis, hepatotoxicity
AnthracyclinesDNA intercalation, Topo II inh., radicalsDoxorubicinLeukemias, lymphomas, sarcomas, WilmsCardiotoxicity (cumulative), myelosuppression
Vinca AlkaloidsInhibit microtubule assembly (M-phase)VincristineLeukemias, lymphomas, solid tumorsNeurotoxicity, constipation, BM sparing

Principles of Pediatric Chemotherapy - Side Effect Battles

Chemotherapy targets rapidly dividing cells, affecting cancer and healthy tissues. Managing side effects is vital.

  • Acute: Myelosuppression, nausea/vomiting, mucositis.
  • Organ-Specific: Cardiac, renal, neurotoxicity.
  • Long-Term: Growth issues, secondary cancers, infertility.

Key Side Effects & Management:

System/ToxicityKey DrugsPeds NotesManagement Highlights
MyelosuppressionMost chemoANC < 500/µL criticalG-CSF, transfusions
Nausea/VomitingCisplatin, DoxoHigh anticipatoryOndansetron, Aprepitant
MucositisMTX, 5-FUPain, poor nutritionHygiene, cryotherapy
Hemorrhagic CystitisCyclophos, IfosAcrolein toxicityMesna, hydration
CardiotoxicityAnthracyclinesCumulative doseDexrazoxane, LVEF monitoring
NeurotoxicityVincristine, CisplatinFoot drop (V), Ototoxic (Cis) 📌 CisPLATinDose adjust
NephrotoxicityCisplatin, MTXMonitor GFRHydration, Leucovorin (MTX)
Tumor Lysis (TLS)ALL, Burkitt'sMetabolic emergencyRasburicase, hydration

Chemotherapy side effects by organ system

Management of Febrile Neutropenia:

Principles of Pediatric Chemotherapy - Dose & Future Watch

  • Dosing:
    • Primarily Body Surface Area (BSA): $\text{BSA (m}^2\text{) = } \sqrt{(\text{Height (cm)} \times \text{Weight (kg)}) / 3600}$.
    • Carboplatin: Calvert formula $\text{Dose (mg) = Target AUC} \times \text{(GFR + 25)}$.
    • Age/weight bands for infants.
  • Pediatric Pharmacokinetics:
    • ↑ GFR, ↑ metabolism (MTX, cyclophosphamide).
    • Larger Vd (water-soluble drugs), ↓ protein binding.
  • Future Watch (Late Effects):
    • Secondary malignancies (e.g., AML post-etoposide).
    • Organ toxicities: cardiac (anthracyclines), pulmonary (bleomycin), renal (cisplatin), neuro (vincristine).
    • Endocrine: growth issues, infertility.
    • Long-term surveillance crucial.

⭐ Anthracyclines (e.g., Doxorubicin) cause dose-dependent cardiotoxicity, potentially years later, requiring long-term cardiac follow-up.

High‑Yield Points - ⚡ Biggest Takeaways

  • BSA-based dosing is standard for most pediatric chemotherapy.
  • Children exhibit higher chemosensitivity due to rapid cell proliferation.
  • Altered PK/PD in children significantly impacts drug efficacy and toxicity.
  • Long-term sequelae, including secondary malignancies and organ damage, are critical.
  • Sanctuary sites (CNS, testes) often require specific therapeutic approaches.
  • Aggressive supportive care is vital for managing treatment toxicities.
  • Pediatric cancers show a unique spectrum (leukemias, lymphomas, embryonal tumors).

Practice Questions: Principles of Pediatric Chemotherapy

Test your understanding with these related questions

Which of the following medications is a first-line antitubercular drug used routinely in children of all age groups without significant monitoring limitations?

1 of 5

Flashcards: Principles of Pediatric Chemotherapy

1/8

Pediatric NHL is usually _____ grade and has a good outcome

TAP TO REVEAL ANSWER

Pediatric NHL is usually _____ grade and has a good outcome

high

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial